
For cancer patients undergoing chemotherapy, there is an onset of a variety of adverse events related to zzso Among the adverse events at the moment is taste disorder, for which there is no established effective supportive zzso We report the measurement and study their relationship across the changes in serum zinc and changes in the taste of patients undergoing zzso For cancer patients undergoing chemotherapy, taste threshold and serum zinc levels were measured on the day before administration of the therapeutic zzso agent, and after administration of zzso drugs on day 4 and day zzso Of taste thresholds in the test results, the threshold was salty on day 4 and day 7 after administration of zzso agents, and a significant difference was found on day 7 after treatment with zzso drugs on a day prior to administration of zzso agents on day 1 zzso zzso zzso zzso zzso The serum zinc level was zzso There was no significant difference on day 7 after administration of zzso agents and zzso agent before administration on day 1 and day 7 after administration of zzso drugs on day zzso zzso zzso zzso zzso A negative correlation was shown between the zzso of the fourth day zzso and zzso zinc zzso zzso zzso zzso zzso From the results of this study, salty and low serum zinc values tended to be zzso The higher the serum zinc level was, the more sensitivity there was to salty zzso 

